Literature DB >> 8064812

The impact of population based screening for carriers of cystic fibrosis.

H Bekker1, G Denniss, M Modell, M Bobrow, T Marteau.   

Abstract

The purpose of the study was to evaluate the short-term effects of population based screening for carriers of cystic fibrosis. The outcome measures included perceptions of health, anxiety, and understanding of test results. Those adults aged between 18 and 45, registered with a general practice in Inner London, who accepted the offer of carrier testing, completed questionnaires before testing, upon receipt of results, and three months later. Full data were obtained from 427 with negative test results and 14 carriers. Receipt of results had no effect upon perceptions of health or perceived risk of having an abnormal baby. Those receiving a positive test result were significantly more anxious upon receipt of this result. By three months, this anxiety had dissipated. While knowledge of the test improved from before to after testing, by three months there was some decay. Although the residual risk among those with a negative result of being a carrier was given as 1:135, at least 17% of those receiving a negative result incorrectly believed that they were at no risk of having a child with cystic fibrosis. Five of the 14 receiving a positive result erroneously believed that their results meant that they probably, but not definitely, carried the gene for cystic fibrosis. In the longer term the greatest problem of population screening would appear to be one of false reassurance rather than anxiety. Longer term studies are needed to determine how well carrier status information is retained, and how carriers and carrier couples plan and respond to pregnancy and how much understanding they retain of their test results.

Entities:  

Keywords:  Empirical Approach; Genetics and Reproduction; Health Care and Public Health

Mesh:

Year:  1994        PMID: 8064812      PMCID: PMC1049866          DOI: 10.1136/jmg.31.5.364

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  8 in total

1.  Mutation analysis of 184 cystic fibrosis families in Wales.

Authors:  J Cheadle; J Myring; L al-Jader; L Meredith
Journal:  J Med Genet       Date:  1992-09       Impact factor: 6.318

2.  Psychological and social consequences of community carrier screening programme for cystic fibrosis.

Authors:  E K Watson; E S Mayall; J Lamb; J Chapple; R Williamson
Journal:  Lancet       Date:  1992-07-25       Impact factor: 79.321

3.  Effects of genetic screening on perceptions of health: a pilot study.

Authors:  T M Marteau; M van Duijn; I Ellis
Journal:  J Med Genet       Date:  1992-01       Impact factor: 6.318

4.  Uptake of cystic fibrosis testing in primary care: supply push or demand pull?

Authors:  H Bekker; M Modell; G Denniss; A Silver; C Mathew; M Bobrow; T Marteau
Journal:  BMJ       Date:  1993-06-12

5.  Why it won't happen to me: perceptions of risk factors and susceptibility.

Authors:  N D Weinstein
Journal:  Health Psychol       Date:  1984       Impact factor: 4.267

6.  A private view of heterozygosity: eight-year follow-up study on carriers of the Tay-Sachs gene detected by high school screening in Montreal.

Authors:  S Zeesman; C L Clow; L Cartier; C R Scriver
Journal:  Am J Med Genet       Date:  1984-08

7.  Prenatal screening for cystic fibrosis.

Authors:  M E Mennie; A Gilfillan; M Compton; L Curtis; W A Liston; I Pullen; D A Whyte; D J Brock
Journal:  Lancet       Date:  1992-07-25       Impact factor: 79.321

8.  The development of a six-item short-form of the state scale of the Spielberger State-Trait Anxiety Inventory (STAI).

Authors:  T M Marteau; H Bekker
Journal:  Br J Clin Psychol       Date:  1992-09
  8 in total
  26 in total

1.  Carrier testing of children for two X linked diseases in a family based setting: a retrospective long term psychosocial evaluation.

Authors:  O Järvinen; A M Aalto; A E Lehesjoki; M Lindlöf; I Söderling; A Uutela; H Kääriäinen
Journal:  J Med Genet       Date:  1999-08       Impact factor: 6.318

2.  Implications of carrier identification in newborn screening for cystic fibrosis.

Authors:  E P Parsons; A J Clarke; D M Bradley
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2003-11       Impact factor: 5.747

3.  Carrier screening in preconception consultation in primary care.

Authors:  Sylvia A Metcalfe
Journal:  J Community Genet       Date:  2011-12-20

4.  Cystic fibrosis carrier population screening in the primary care setting.

Authors:  S Loader; P Caldwell; A Kozyra; J C Levenkron; C D Boehm; H H Kazazian; P T Rowley
Journal:  Am J Hum Genet       Date:  1996-07       Impact factor: 11.025

Review 5.  Can we make assumptions about the psychosocial impact of living as a carrier, based on studies assessing the effects of carrier testing?

Authors:  Celine Lewis; Heather Skirton; Ray Jones
Journal:  J Genet Couns       Date:  2010-09-29       Impact factor: 2.537

6.  Genetic testing in asymptomatic minors: background considerations towards ESHG Recommendations.

Authors:  Pascal Borry; Gerry Evers-Kiebooms; Martina C Cornel; Angus Clarke; Kris Dierickx
Journal:  Eur J Hum Genet       Date:  2009-03-11       Impact factor: 4.246

7.  Attitudes of potential providers towards preconceptional cystic fibrosis carrier screening.

Authors:  Francis A M Poppelaars; Herman J Adèr; Martina C Cornel; Lidewij Henneman; Rosella P M G Hermens; Gerrit van der Wal; Leo P ten Kate
Journal:  J Genet Couns       Date:  2004-02       Impact factor: 2.537

Review 8.  Social and psychological issues associated with the new genetics.

Authors:  S Macintyre
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1997-08-29       Impact factor: 6.237

9.  Attitudes towards bipolar disorder and predictive genetic testing among patients and providers.

Authors:  L B Smith; B Sapers; V I Reus; N B Freimer
Journal:  J Med Genet       Date:  1996-07       Impact factor: 6.318

10.  Cystic fibrosis heterozygote screening in 5,161 pregnant women.

Authors:  D R Witt; C Schaefer; P Hallam; S Wi; B Blumberg; A Fishbach; J Holtzman; S Kornfeld; R Lee; L Nemzer; R Palmer
Journal:  Am J Hum Genet       Date:  1996-04       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.